Antipsychotics: Treatment Response

Treatment response is the degree of improvement associated with a treatment over an appropriate period. It can be measured through symptoms, distress, functioning and the person’s own priorities. A partial response may still be valuable, while an apparently strong symptom response can be undermined by intolerable adverse effects.

Antipsychotics are medicines used to treat psychotic symptoms and, for some drugs, other conditions. Most established agents act through dopamine D2 receptors, with substantial differences in additional targets and pharmacology. Benefits and adverse effects vary between medicines and individuals, so treatment is assessed through observed outcomes rather than the drug’s label alone.

Assessment considers whether treatment was taken and absorbed consistently, whether the trial was adequate and whether other problems are maintaining symptoms. Substance use, physical illness and diagnostic uncertainty may matter. Response should not be judged only from sedation or short-term changes in behaviour. Some benefits develop over weeks, and different domains improve at different rates. Documenting baseline difficulties and specific goals makes review more informative. When treatment is insufficient, clinicians explore the reasons before assuming that increasing the dose or adding another medicine is necessarily the best next step.

Response can be separated into effectiveness and tolerability. A medicine may clearly reduce psychosis yet remain difficult to continue because of restlessness, weight change or sexual effects. Conversely, good tolerability alone does not establish adequate symptom control. Recording both dimensions supports a balanced comparison and helps explain why the preferred treatment may differ between people with similar symptom descriptions.

Further reading: National Institute of Mental Health; Research record 10739409; DailyMed prescribing information.